SMi’s 2nd Annual AI in Drug Discovery Announces key industry speakers and agenda released
SMi’s Group is proud to announce the 2nd Annual AI in Drug Discovery Conference is back and taking place on 15th and 16th March 2021 as a virtual conference with online access only and sponsored by OpenEye Scientific Software.
This year’s event will delve into the latest innovations in machine learning for enhancing discovery pipelines. Furthermore the two-day virtual conference will focus on 4 key themes: machine learning and automation for improved drug discovery pipelines; effective prediction of compound properties; data robustness and curation; innovative use of AI for rare and undruggable diseases, and will highlight key case studies across these themes, uncovering key developments in pharma of data optimization and to aid therapeutic discovery. Real-world examples of AI in structure-based drug design and patient relevant data will be explored in eye-opening detail.
SMi Group is proud to announce the chair for the conference Darren Green, Director of Molecular Design & Senior Fellow, GSK
Key Expert Speakers include:
• Noor Shaker, CEO, GlamorousAI
• Maria Luisa Pineda, Co-Founder & CEO, Envisagenics
• Ed Addison, Co-founder, Chairman & CEO, Cloud Pharmaceuticals
• Liling Warren, Director, Head of Translational Medicine Statistics, Teva Pharmaceuticals
• Lili Peng, Associate Director Scientific Ecosystem Analytics Lead, Biogen
• Mark De Pristo, CEO, BigHat Biosciences
• Philipe Moingeon, Head of Immuno-inflammation, Servier
• Hugo Ceulemans, Scientific Director, Discovery Data Sciences, Janssen
• Peter Henstock, Machine Learning & AI Lead, Pfizer
• Naheed Kurji, CEO, Cyclica
To view the full speaker line-up and 2-day agenda please click on this link
Key highlights for the 2021 conference include, discovering the latest innovations in AI-based drug discovery platforms, engaging in case study presentations from leading pharma and biotech companies on machine learning and improved drug discovery pipelines, understanding how AI can be effectively implemented to enhance productivity, delving into best practices in data quality, curation, and validation and exploring how AI is being used to unlock therapies that have evaded traditional drug discovery.
If you are interested in participating and attending the conference, you can register your free place at http://www.ai-indrugdiscovery.com/PR1.
Are you interested in sponsoring, exhibiting or speaking at this event, contact Alia Malick, Director, on +44 (0) 20 827 6168 or email firstname.lastname@example.org
For media enquiries, contact Simi Sapal on +44 (0) 20 7827 6162 or email@example.com
SMi’s 2nd Annual AI in Drug Discovery Conference 2021
15 & 16 March 2021
Virtual Conference: Online Access Only
Follow us @SMiPharm
---- END ----
About SMi Group: Established since 1993, the SMi Group is a global event-production company that specializes in Business-to-Business Conferences, Workshops, Masterclasses and online Communities. We create and deliver events in the Defence, Security, Energy, Utilities, Finance and Pharmaceutical industries. We pride ourselves on having access to the world’s most forward-thinking opinion leaders and visionaries, allowing us to bring our communities together to Learn, Engage, Share and Network. More information can be found at http://www.smi-online.co.uk